Ishita Drugs & Industries Share Price

Ishita Drugs & Industries

CMP as on06-Dec-22 13:08

₹ 49.65
-2.35 -4.52%


₹ 50.60

Turnover (lac)

₹ 1

Prev. Close

₹ 52.00

Day's Vol (shares)

₹ 1,244

Day's Range

₹ 49.55
₹ 52.40

Ishita Drugs & Industries was incorporated in Feb.92 by Jagdish Agarwal. The company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.95.Recession in some international markets and intense dumping of the Chinese exporters of the bulk drugs originally planned in the product range, necessiated a review by the company of its production programme and product range. It decided to undertake production of fluoro-quinolones, the latest broad spectrum anti-bacterials. The company established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin. The in-house process technology for norfloxacin was implemented in its plant in Oct.95.

  • Managing Director

    Jagdish Agrawal
  • Independent Director

    Govind Gupta
  • Director

    Abha Agrawal
  • Independent Director

    Niranjan Agrawal
  • Independent Director

    Arvind Sapkal
  • Company Sec. & Compli. Officer

    Srushti Pandya

Registered Office

Survey No 179/1 Taluka Sanand,
Village Vasna-Iyava,Ahmedabad,


E-2/3 Saki Vihar Rd,
Saki Naka Andheri-E,Mumbai - 400 072